Health & Biotech
Check out the latest news, insights and unique analysis brought to you by Stockhead's team of business journalists and industry experts on Nyrada.
RELATED STOCKHEAD STORIES
News
Rise and Shine: Everything you need to know before the ASX opens
News
Closing Bell: ASX falls flat after strong employment data muddies waters
News
ASX Small Caps and IPO Weekly Wrap: 30 hours of hot ASX action and we’re right back where we started
Health & Biotech
ASX Health Stocks: Silk Laser gives thumbs up to $180 million Wesfarmers bid, soars 18%
Health & Biotech
ASX Health Stocks: Anteris’ 3D heart valve shows consistent results; as Nyrada announces a new lead drug
News
Market Highlights: Wall Street enters bull territory; Bitcoin whale makes $38m after a 10-year hodl
Health & Biotech
ASX Health Stocks: MVP flies high after disclosing US ‘green whistle’ strategy, Imricor signs with prestigious Swiss hospital
Experts
MoneyTalks: Canary Capital’s Paul Hart reckons these are the biotech stocks to pop in the basket
News
Market Highlights: Wall Street gains, Aussie CPI ahead, and 5 ASX small caps to watch on Wednesday
News
Market highlights and 5 ASX small caps to watch on Wednesday
News
‘Ridiculous selling’: Small cap fund managers on buying the panic and where the bargains are
Experts
MoneyTalks: ASX biotechnology shares are deeply discounted – Paul Hart says ‘perfect time’ to buy
Health & Biotech
ASX Health Stocks: Clarity Pharma gets the go-ahead from US FDA
News
Market highlights and 5 ASX small caps to watch on Monday
Experts
MoneyTalks: Tony Locantro’s 3 contrarian biotech picks in a time of market volatility
Health & Biotech
ASX Health Stocks: Nyrada gets closer to European patent, and HOPE for Zelira’s autism tincture
News